Are pediatricians ready for the new guidelines on lead poisoning?

M E Bar-on1, R M Boyle

  • 1Department of Pediatrics, Children's Medical Center, Richmond, VA 23298.

Pediatrics
|February 1, 1994
PubMed

Insights

Pediatricians show knowledge gaps regarding lead poisoning, despite 1991 CDC guidelines. Improved physician education and modified screening practices are crucial for effective lead poisoning prevention.

Area of Science:

  • Public Health
  • Pediatrics
  • Environmental Health

Background:

  • The Centers for Disease Control (CDC) issued new guidelines in 1991 for defining and screening lead poisoning.
  • Lead poisoning remains a significant public health concern, particularly in children.

Purpose of the Study:

  • To evaluate pediatricians' understanding of current lead poisoning literature and their screening behaviors.
  • To identify areas for improvement in pediatrician knowledge and practices related to lead poisoning.

Main Methods:

  • A validated 22-item questionnaire was mailed to 1183 self-designated pediatricians in Virginia.
  • Survey responses were analyzed to assess knowledge levels and screening practices.

Main Results:

  • A significant deficiency in knowledge about lead poisoning was observed among respondents (mean correct responses: 15.7 +/- 3.4).
  • Primary care pediatricians demonstrated better knowledge than subspecialists (16.2 +/- 3.0 vs. 14.7 +/- 4.1).
  • Only 12% of pediatricians reported screening all their patients for lead poisoning.

Conclusions:

  • Pediatrician knowledge regarding lead poisoning requires enhancement, with specific gaps in understanding recent literature.
  • Current screening practices for lead poisoning are insufficient and need modification.
  • Prioritizing physician education is essential for the successful implementation of CDC lead poisoning guidelines.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...